Zacks Research Forecasts Lower Earnings for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Investment analysts at Zacks Research reduced their Q1 2025 EPS estimates for Teladoc Health in a research report issued to clients and investors on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings per share of ($0.40) for the quarter, down from their prior forecast of ($0.38). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health’s Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($1.08) EPS, Q2 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.11) EPS and FY2026 earnings at ($0.90) EPS.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%.

Other research analysts also recently issued reports about the stock. Royal Bank of Canada lifted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Piper Sandler lowered their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. The Goldman Sachs Group cut their target price on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, March 3rd. Bank of America upped their price target on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research report on Wednesday, February 12th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $11.26.

Teladoc Health Stock Up 2.8 %

Shares of NYSE:TDOC opened at $8.86 on Monday. The stock has a market capitalization of $1.54 billion, a P/E ratio of -1.54 and a beta of 1.27. The stock’s 50-day moving average price is $10.54 and its 200-day moving average price is $9.73. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $15.68.

Hedge Funds Weigh In On Teladoc Health

Hedge funds have recently added to or reduced their stakes in the company. Arizona State Retirement System increased its holdings in Teladoc Health by 1.8% in the 4th quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider’s stock worth $452,000 after buying an additional 859 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its holdings in shares of Teladoc Health by 9.6% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider’s stock valued at $113,000 after acquiring an additional 1,089 shares during the last quarter. Canada Pension Plan Investment Board grew its stake in shares of Teladoc Health by 0.5% in the fourth quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider’s stock worth $2,079,000 after acquiring an additional 1,200 shares during the period. Summit Investment Advisors Inc. raised its holdings in shares of Teladoc Health by 8.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock valued at $164,000 after purchasing an additional 1,331 shares during the last quarter. Finally, Vise Technologies Inc. lifted its position in Teladoc Health by 4.9% during the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 1,405 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.